StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
40
Publishing Date
2021 - 10 - 07
40
Sector
Commercial services
1
Communications
2
Electronic technology
2
Finance
1
Health technology
31
Manufacturing
1
Professional, scientific, and technical services
3
Tags
Acquisition
1
Alliances
2
Antibody
1
Application
2
Biocanada
3
Biocapital
2
Biomidwest
1
Bioscience
1
Biotech
1
Biotech-beach
1
Biotechnology
5
Cancer
13
Children
1
Clinical hold
1
Clinical-trials-phase-ii
1
Collaboration
3
Conference
13
Dementia
1
Designation
1
Disease
3
Europe
1
Events
1
Expansion
1
Fda
2
Fibrosis
1
Funding
1
Gene therapy
1
Genetown
2
Grant
1
Granted
2
Iot
1
Liver
1
Lung cancer
1
Molecular
11
Money
1
N/a
12
New-companies
1
Offering
1
Ongoing
2
Patent
2
Pd-1 inhibitor
1
People
1
Pharm-country
1
Phase 1
3
Pimivalimab
1
Potential
1
Pre-clinical
4
Preclinical
4
Presentation
4
Prostate cancer
1
Rare
1
Rare pediatric disease designation
1
Research
8
Results
2
Retina
2
T-cell
2
Therapeutics
4
Therapy
3
Treatment
6
Trial
3
Entities
Acer therapeutics inc.
2
Aditx therapeutics, inc.
1
Allogene therapeutics, inc.
1
Amgen inc.
1
Aptevo therapeutics inc.
1
Beigene, ltd.
1
Bicycle therapeutics plc
1
Calliditas therapeutics ab
1
Century therapeutics inc
1
Cerevel therapeutics holdings, inc.
1
Cidara therapeutics, inc.
1
Cts corporation
2
Eli lilly and company
1
Forma therapeutics holdings, inc.
1
Gilead sciences, inc.
2
Global blood therapeutics, inc.
1
Immunoprecise antibodies ltd
1
Imv inc.
1
Jounce therapeutics, inc.
1
Lava therapeutics nv
2
Medicenna therapeutics corp.
1
Merus n.v.
1
Mirati therapeutics, inc.
1
Monte rosa therapeutics inc
1
Ocuphire pharma inc.
1
Orange
2
Outlook therapeutics, inc.
1
Ovid therapeutics inc.
1
Pfizer, inc.
1
Phio pharmaceuticals corp.
1
Pliant therapeutics, inc.
1
Prelude therapeutics incorporated
1
Rain therapeutics inc
1
Relay therapeutics, inc.
1
Repare therapeutics inc.
1
Salarius pharmaceuticals, inc.
1
Sanofi
2
Silence therapeutics plc
1
Turning point therapeutics, inc.
1
Y-mabs therapeutics, inc.
1
Symbols
ACER
2
ADTX
1
ALLO
1
AMGN
1
APVO
1
BCYC
1
BGNE
1
CALT
1
CDTX
1
CERE
1
CTS
2
FMTX
1
FNCTF
2
GBT
1
GILD
2
GLUE
1
IMV
1
IPA
1
IPSC
1
JNCE
1
LLY
1
LVTX
2
MDNA
1
MRTX
1
MRUS
1
OCUP
1
OTLK
1
OVID
1
PFE
1
PHIO
1
PLRX
1
PRLD
1
RAIN
1
RLAY
1
RPTX
1
SLN
1
SLNCF
1
SLRX
1
SNY
2
SNYNF
2
TPTX
1
YMAB
1
Exchanges
Nasdaq
37
Nyse
4
Crawled Date
2024 - 04 - 09
40
2024 - 03 - 05
44
2024 - 01 - 08
49
2024 - 01 - 04
46
2024 - 01 - 03
40
2024 - 01 - 02
42
2023 - 11 - 13
43
2023 - 11 - 09
63
2023 - 11 - 07
52
2023 - 11 - 06
44
2023 - 11 - 02
50
2023 - 11 - 01
59
2023 - 10 - 31
46
2023 - 10 - 30
38
2023 - 10 - 04
47
2023 - 09 - 11
38
2023 - 09 - 07
38
2023 - 09 - 06
51
2023 - 09 - 05
62
2023 - 08 - 14
41
2023 - 08 - 10
42
2023 - 08 - 03
43
2023 - 06 - 01
56
2023 - 05 - 15
44
2023 - 05 - 11
58
2023 - 05 - 10
39
2023 - 05 - 09
45
2023 - 05 - 04
46
2023 - 05 - 03
38
2023 - 05 - 02
39
2023 - 05 - 01
69
2023 - 04 - 27
37
2023 - 03 - 15
39
2023 - 03 - 07
49
2023 - 03 - 06
39
2023 - 03 - 01
47
2023 - 02 - 28
41
2023 - 02 - 09
42
2023 - 02 - 02
38
2022 - 11 - 14
38
2022 - 11 - 10
38
2022 - 11 - 03
42
2022 - 03 - 01
44
2022 - 01 - 04
38
2021 - 12 - 13
41
2021 - 11 - 15
42
2021 - 11 - 12
40
2021 - 11 - 10
45
2021 - 11 - 09
40
2021 - 10 - 07
40
2021 - 09 - 13
41
2021 - 09 - 07
40
2021 - 05 - 06
38
2021 - 04 - 27
39
2021 - 03 - 11
39
2021 - 03 - 04
49
2020 - 12 - 15
45
2020 - 12 - 03
67
2020 - 12 - 02
39
2020 - 12 - 01
55
Crawled Time
09:00
2
12:00
8
12:15
3
13:00
5
13:15
7
14:15
1
15:00
1
17:00
1
18:00
1
21:00
5
22:00
2
23:00
4
Source
investors.phiopharma.com
1
www.acertx.com
1
www.biospace.com
28
www.globenewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
crawled date :
2021 - 10 - 07
save search
Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Granted Rare Pediatric Disease Designation by FDA
Published:
2021-10-07
(Crawled : 23:00)
- biospace.com/
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
-45.33%
|
O:
0.97%
H:
3.54%
C:
-1.49%
disease
treatment
fda
rare pediatric disease designation
granted
designation
rare
Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 23:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
230.13%
|
O:
0.56%
H:
2.18%
C:
1.77%
presentation
molecular
cancer
conference
Prelude Therapeutics Announces Presentation of Encouraging Data from Multiple Programs at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 23:00)
- biospace.com/
PRLD
|
$3.91
1.03%
1.02%
29K
|
Health Technology
|
-86.55%
|
O:
-14.52%
H:
0.0%
C:
-29.51%
presentation
molecular
cancer
conference
Repare Therapeutics Issues Statement Regarding Inadvertent Issuance of Phase 1/2 TRESR RP-3500 Clinical Trial Abstract by the AACR-NCI-EORTC Virtual International Conference
Published:
2021-10-07
(Crawled : 23:00)
- biospace.com/
RPTX
4
|
$3.3
-1.79%
-1.82%
73K
|
Health Technology
|
-86.76%
|
O:
-0.32%
H:
0.28%
C:
-11.87%
phase 1
trial
conference
Aditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021
Published:
2021-10-07
(Crawled : 22:00)
- biospace.com/
ADTX
|
$2.27
2.84%
27K
|
Health Technology
|
50.96%
|
O:
-1.91%
H:
8.31%
C:
4.55%
Immunotherapeutic Benefits of the DPX Delivery Platform Featured in Two Poster Presentations at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 22:00)
- biospace.com/
IMV
|
$0.8225
-2.74%
45K
|
Health Technology
|
-49.07%
|
O:
0.93%
H:
1.84%
C:
-1.84%
presentation
molecular
cancer
liver
conference
LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 21:00)
- biospace.com/
LVTX
|
$2.77
-7.05%
-7.58%
150K
|
|
-56.09%
|
O:
-3.3%
H:
5.92%
C:
0.77%
treatment
molecular
cancer
conference
t-cell
Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock
Published:
2021-10-07
(Crawled : 21:00)
- biospace.com/
CDTX
|
News
|
$11.94
16.49%
14.15%
170K
|
Health Technology
|
486.84%
|
O:
0.0%
H:
0.0%
C:
-1.58%
offering
Allogene Therapeutics Reports FDA Clinical Hold of AlloCAR T Trials Based on a Single Patient Case in ALPHA2 Trial
Published:
2021-10-07
(Crawled : 21:00)
- biospace.com/
ALLO
|
$3.04
-9.79%
-10.86%
2.1M
|
Health Technology
|
-87.32%
|
O:
0.42%
H:
3.86%
C:
1.29%
fda
trials
trial
clinical hold
Bicycle Therapeutics Announces Interim BT5528 Phase I Clinical Trial Results and Preliminary Results from Ongoing BT8009 Phase I Clinical Trial
Published:
2021-10-07
(Crawled : 21:00)
- biospace.com/
BCYC
|
$22.7
0.09%
0.09%
520K
|
Health Technology
|
-45.64%
|
O:
-1.13%
H:
21.05%
C:
18.09%
ongoing
results
trial
trial results
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer
Published:
2021-10-07
(Crawled : 21:00)
- biospace.com/
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-5.15%
|
O:
-4.14%
H:
5.79%
C:
5.79%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.57%
|
O:
0.21%
H:
0.95%
C:
0.62%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-63.4%
|
O:
-1.07%
H:
8.36%
C:
4.51%
lung cancer
phase 1
cancer
CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 18:00)
- globenewswire.com
LVTX
|
$2.77
-7.05%
-7.58%
150K
|
|
-56.09%
|
O:
-3.3%
H:
5.92%
C:
0.77%
treatment
molecular
cancer
conference
t-cell
Intergalactic Therapeutics Launches with $75 Million Series A
Published:
2021-10-07
(Crawled : 17:00)
- biospace.com/
CTS
|
News
|
$45.64
0.33%
0.0%
94K
|
Electronic Technology
|
46.0%
|
O:
0.99%
H:
1.71%
C:
0.7%
therapeutics
GBT Announces New Employment Inducement Grants
Published:
2021-10-07
(Crawled : 15:00)
- globenewswire.com
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
169.5%
|
O:
5.12%
H:
6.14%
C:
4.12%
granted
grant
Rain Therapeutics Presents Data on Milademetan (RAIN-32) at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 14:15)
- globenewswire.com
RAIN
|
$1.21
0.0%
3.7M
|
Manufacturing
|
-91.86%
|
O:
-0.54%
H:
2.3%
C:
-7.71%
molecular
cancer
conference
Phio Pharmaceuticals Presents New BRD4 Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 13:15)
- investors.phiopharma.com
PHIO
|
News
|
$0.672
-4.0%
-4.17%
91K
|
Health Technology
|
-62.36%
|
O:
2.81%
H:
0.55%
C:
-0.55%
molecular
cancer
conference
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
Published:
2021-10-07
(Crawled : 13:15)
- biospace.com/
IPA
|
$1.22
-0.81%
23K
|
Professional, Scientific, and T...
|
-79.43%
|
O:
0.67%
H:
13.59%
C:
3.18%
collaboration
antibody
research
Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer
Published:
2021-10-07
(Crawled : 13:15)
- globenewswire.com
GLUE
|
$5.46
-1.44%
-1.47%
83K
|
Professional, Scientific, and T...
|
-72.15%
|
O:
0.1%
H:
3.64%
C:
-2.44%
treatment
rosa
potential
molecular
cancer
preclinical
pre-clinical
Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors
Published:
2021-10-07
(Crawled : 13:15)
- biospace.com/
OVID
|
$3.165
-1.09%
-1.11%
110K
|
Health Technology
|
-8.43%
|
O:
0.0%
H:
5.23%
C:
4.36%
therapeutics
Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published:
2021-10-07
(Crawled : 13:15)
- globenewswire.com
MRUS
|
$41.96
2.79%
2.72%
740K
|
Health Technology
|
109.85%
|
O:
45.75%
H:
2.13%
C:
-5.69%
molecular
cancer
conference
preclinical
pre-clinical
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.